Synthetic Biology Remains A Mystery
National survey finds three out of four adults have heard little or nothing about the emerging technology
WASHINGTON, March 20, 2013 /PRNewswire-USNewswire/ -- Despite advancements in the field of synthetic biology, three out of four adults surveyed in a national poll released today have heard "just a little" or "nothing at all" about the emerging technology, a level of awareness that has changed little since 2010.
The national poll of more than 800 U.S. adults conducted by Hart Research Associates and the Synthetic Biology Project at the Woodrow Wilson International Center for Scholars finds that there has only been a minor shift in public awareness of synthetic biology, an area of research focused on the design and construction of new biological parts and devices, or re-design of existing biological systems.
"Given these low levels of awareness about synthetic biology, attitudes about the technology are still largely unformed," said David Rejeski, director of the Synthetic Biology Project. "The information people receive about the science and its applications will be critical to how the public feels about this technology going forward."
As the public learns more about synthetic biology, there is greater movement toward concern about risk than optimism about benefits, the poll finds. After hearing some basic information about synthetic biology, 33 percent of adults express greater concern about risks from the technology, while 24 percent express more optimism about its benefits. "This survey reveals the American public's nuanced and varied impressions of synthetic biology depending on the information provided and the application in question," said Abigail Davenport, a partner with Hart Research. "While the majority would like to see the science proceed, there are several findings that highlight the public's call for caution in moving ahead." The public has divided opinions on the future of synthetic biology and the role of government regulation. While 61 percent think the science should move forward, one-third of respondents favor a ban "on synthetic biology research until we better understand its implications and risks."Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
